Explore the Individual Treatment of Docetaxel and Paclitaxel in NSCLC, NPC and BRC by PK-guided Dosing Strategy
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Non-small Cell Lung Cancer|Breast Cancer|Nasal Cancer
Interventions: DEVICE: PK guided arm|DRUG: PTX 175mg/m2, DOC 75mg/m2
Sponsor: Sun Yat-sen University